Study on the Preventive Effects of Chitraka Haritaki Avaleha in Recurrent Upper Respiratory Illness in Children: A Randomized Controlled Clinical Trial

Abstract

Background: Upper respiratory illnesses are the most frequently occurring illness in childhood and it can decrease quality of life for children. The cause of recurrence of these illnesses is linked to relative immaturity of the immune system.  Increasing bacterial resistance in recent years has shifted focus more on prevention of recurrent upper respiratory illness in children. The aim of study is to evaluate the immune modulator effect of Chitraka haritaki avaleha and its preventive effects of recurrent upper respiratory illness in children. Objectives  - To evaluate and compare the immune-modulator effects of control and trial drugs in children suffering from recurrent upper respiratory tract illness through AEC, IgG, IgE levels. Methodology-  The patients attending the  OPD and IPD of the department of Kaumarbhritya, MahatmaGandhi Ayurved College, Hospital and Research Centre, Salod (H), Wardha  will be diagnosed as Upper Recurrent Respiratory Illness on the basis of diagnostic criteria and after fulfilling inclusive criteria, randomly such patients will be enrolled for the study. The enrolled patients will be divided into two groups, patients of one group will be received Chitraka Haritaki Avaleha and other group will be received Chyavanprash Avaleha for 60 days. Follow up of 60 days will be done and after that the effects of the therapy will be assessed for IgG and IgE. Expected Results- Chitraka haritaki avaleha is a preventive in recurrent upper respiratory illness in paediatric patients. Conclusion- Preventive focus in Recurrent Upper Respiratory Illness in children will help to restore the health of the children and improve the quality of life. Children with impaired immune responses may benefit from chitraka haritaki avaleha. There is need to gain more data insights in Indian children from larger studies.